Insilico Medicine 17 jun 2026 Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics - Insilico Medicine
Insilico Medicine 4 jun 2026 Insilico Medicine founder and CEO Alex Zhavoronkov recognized in inaugural SCW75 for pioneering AI-driven drug discovery and longevity research - EurekAlert!
Insilico Medicine 3 jun 2026 Insilico Medicine appoints Jue Wang, PhD as Global Head of Business Development - EurekAlert!
Insilico Medicine 3 jun 2026 Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development - Insilico Medicine
Insilico Medicine 3 jun 2026 Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development - Insilico Medicine
Insilico Medicine 29 may 2026 Insilico Medicine to showcase AI-driven innovation at BIO 2026 International Convention - EurekAlert!
Insilico Medicine 27 may 2026 Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science - Insilico Medicine
Insilico Medicine 22 may 2026 Insilico Medicine and Saudi Aramco Introduce the “Sanity Pipeline” to Advance AI-driven Discovery of MOFs - Insilico Medicine
Insilico Medicine 22 may 2026 Insilico Medicine and Saudi Aramco Introduce the “Sanity Pipeline” to Advance AI-driven Discovery of MOFs - Insilico Medicine
Insilico Medicine 18 may 2026 A Look At InSilico Medicine (SEHK:3696) Valuation After Recent Share Price Pullback - simplywall.st
Insilico Medicine 17 may 2026 InSilico Ribo Oligonucleotide Alliance Tests AI Drug Discovery Model - simplywall.st
Insilico Medicine 17 may 2026 Insilico Medicine Showcases AI-Driven Inhaled Therapy for Pulmonary Fibrosis at ATS Summit - TipRanks
Insilico Medicine 13 may 2026 Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development - BioPharma APAC
Insilico Medicine 12 may 2026 Ribo, Insilico Medicine to Partner on AI-Driven siRNA Drug Development - Contract Pharma
Insilico Medicine 12 may 2026 Insilico Medicine and Ribo enter strategic collaboration agreement: Leveraging AI platform and automated lab for end-to-end empowerment of RNA interference and oligonucleotide therapeutics development - EurekAlert!
Insilico Medicine 12 may 2026 Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI - Yahoo Finance UK
Insilico Medicine 7 may 2026 Advancing Drug Discovery from Automation to Autonomy: Insilico Medicine Announces LabClaw the Intelligent System - Insilico Medicine
Insilico Medicine 7 may 2026 Advancing Drug Discovery from Automation to Autonomy: Insilico Medicine Announces LabClaw the Intelligent System - Insilico Medicine